Gizmodo60%
China Just Performed the World’s First Implant of a Commercial Brain-Computer Interface 17%
By Webb Wright49%
7/15/2026, 11:00:18 PM
BS Summary: This article contains 24 faulty reasoning types, including Appeal to Authority, Biased Writer Voice, and Optimism Bias, with Ambiguity (Equivocation) as the most egregious example at 37.7% saturation with 168 hits. Analysis detected 1,278 faulty-reasoning hits from 446 analyzed words, generating a BS Score of 32.2% and a BS Rank of 17% (13,520 of 16,139 articles). This article is better (less manipulative) than 83.80% of the article peer group.
China is determined to become a global leader in the burgeoning market for brain-computer interfaces, or BCIs.
This week, it took a big step towards achieving that goal.
Multiple Chinese news outlets reported on Wednesday that Chinese neurotechnology firm Neuracle (also known as Borui Kang Medical Technology) had performed the world’s first successful surgical implant of a commercial BCI in the brain of a patient who’d lost mobility in his hand following a spinal cord injury a decade ago.
The device—called Neural Electronic Opportunity, or NEO—is roughly the size of a coin.
It contains eight electrodes and is surgically implanted onto the surface of the brain’s sensorimotor cortex, where it records electrical signals fired between neurons as a patient imagines moving their hand.
It then sends those signals to a computer, which translates them into motor signals enacted by a robotic glove worn by a patient.
NEO was approved by China’s National Medical Products Association in March, making it the first invasive BCI to be given the thumbs-up for commercial use by a national regulatory agency.
It’s a big win for Neuracle as it ramps up its competition with Elon Musk’s Neuralink.
In 2024, that company successfully implanted a BCI in a human brain—though that was not the first ever successful BCI.
Neuralink has yet to receive approval from the Food and Drug Administration, a required step before bringing a new medical treatment or drug to market in the U.S.
Musk’s company said earlier this year that it had twenty-one people enrolled in clinical trials.
While China’s Neuracle and Musk’s Neuralink have thus far focused their efforts on surgical implants—which obviously carry a fair bit of risk for patients—other companies have been connecting the human body to computers through other, less invasive routes.
Last month, for example, Meta unveiled the latest version of its Brain2Qwerty system, which leverages a large language model to translate brain activity into written text.
The company said that tool could help people suffering from ALS and other neurodegenerative illnesses who have lost the ability to speak to once again be able to communicate their thoughts to others.
Another Chinese firm called BrainCo, meanwhile, has developed a bionic prosthetic hand that operates using AI and a technique called electromyography.
While Chinese AI developers have been racing to catch up with their American counterparts, the country is also investing heavily in its national efforts to build BCIs.
They were one of the core priorities outlined earlier this year by the Chinese government’s latest five-year plan, along with quantum computing, AI-powered robots, nuclear fusion, and other key strategic technologies, according to Reuters.
Analysis
Hover over highlighted words in the article to view the associated bias or fallacy analysis.